Urticaria and/or angioedema secondary to mRNA COVID-19 vaccines: Updates from a United States case registry

Allergy. 2023 Jan;78(1):283-286. doi: 10.1111/all.15447. Epub 2022 Aug 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angioedema* / etiology
  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • RNA, Messenger
  • United States / epidemiology
  • Urticaria* / etiology

Substances

  • COVID-19 Vaccines
  • RNA, Messenger